Ex-Dialysis Co. Execs Can't Dodge SEC Accounting Fraud Suit

By Emilie Ruscoe · March 24, 2023, 6:07 PM EDT

Three former financial executives of dialysis company American Renal Associates Holdings Inc. must face U.S. Securities and Exchange Commission claims they cooked the company's books by more than $39 million in...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

Securities and Exchange Commission v. Jonathan L. Wilcox, et al

Case Number

Court

Massachusetts

Nature of Suit

Securities/Commodities

Date Filed

April 29, 2022

Recent Articles By Emilie

January 07, 2025
Obesity Drug Maker Faces Investor Suit Over IPO Disclosures
January 06, 2025
Biotech Co. Revance Faces Suit After Tender Offer Weakens
January 02, 2025
Eye Drug Study Blindsided Pharma Co. Investors, Suit Says
December 16, 2024
Ginkgo Bioworks Investors Get Final OK Of $17.8M Settlement
December 13, 2024
Pharma Co. Brass Face Investor Suit Over Drug Trial Probe
December 06, 2024
Two Firms To Rep CVS Investors In Benefit Unit Losses Suit
November 05, 2024
Bright Health Beats Investor Suit Over COVID-19 Costs
October 30, 2024
LA Times Owner Faces Investor Suit Over Drug Co.'s Woes
October 28, 2024
Moderna Brass Hit With Investor Suit Over RSV Shot Claims
October 22, 2024
Pharma Co. Verrica Faces Derivative Suit Over FDA Inspection